Shentracon Chemicals Limited has successfully concluded its Board of Directors meeting on February 13, 2026, where the board considered and approved the unaudited standalone financial results for the quarter and nine months ended December 31, 2025. The meeting, which was previously scheduled and announced on February 9, 2026, was conducted in accordance with regulatory requirements.

Board Meeting Outcome

The Board of Directors meeting commenced at 5:00 p.m. and concluded at 5:40 p.m. on February 13, 2026. During the meeting, the board reviewed and approved the company's unaudited standalone financial results for the third quarter of fiscal year 2026 and the nine-month period ending December 31, 2025.

Regulatory Compliance and Documentation

The financial results have been reviewed by the company's Audit Committee and are accompanied by a Limited Review Report issued by the Statutory Auditors. The company has submitted the approved financial results along with the auditor's report to stock exchanges as required under regulatory guidelines.

Stock Exchange Communication

Shentracon Chemicals Limited has formally communicated the outcome to BSE Limited (Scrip Code: 530757) and The Calcutta Stock Exchange Ltd (Scrip Code: 29095). The company has requested both exchanges to disseminate this information on their respective websites as deemed appropriate.

Company Information

Shentracon Chemicals Limited operates under CIN L24299WB1993PLC059449 with its registered office at 6A, Kiran Sankar Roy Road, Kolkata-700001. The communication was digitally signed by Amit Lalit Jain, Managing Director (DIN: 05263766), at 6:10 p.m. on February 13, 2026, confirming the completion of the board meeting and approval of financial results.

The mandatory open offer for Shentracon Chemicals Limited concluded with zero participation from public shareholders, as revealed in the post-offer advertisement published on February 12, 2026. The offer was made by Mr. Amit Lalit Jain and Mr. Hanish Kanakraj Jaain following their acquisition of a controlling stake in the chemical company.

Open Offer Details and Response

The acquirers had offered to purchase up to 11,53,917 fully paid-up equity shares of face value ₹ 10.00 each, representing 26.00% of the company's equity and voting share capital. The offer was priced at ₹ 0.50 per equity share and remained open from January 12, 2026 to January 27, 2026.

Background Acquisition

The open offer was triggered following the acquirers' purchase of 23,17,343 equity shares representing 52.22% of the equity and voting share capital through a Share Purchase Agreement dated September 04, 2025. Prior to this agreement, both acquirers held zero shares in Shentracon Chemicals Limited.

Shareholding Impact

Due to the lack of response to the open offer, the post-acquisition shareholding structure differs significantly from the projected scenario:

Regulatory Compliance

The open offer was conducted in accordance with Regulation 3(1) and 4 of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Bonanza Portfolio Limited served as the Manager to the Offer, while Purva Sharegistry (India) Private Limited acted as the Registrar.

The post-offer advertisement was published in multiple newspapers including Financial Express, Jansatta, Mumbai Lakshadeep, and Duranta Barta, fulfilling the regulatory requirements under Regulation 18(12) of the SEBI SAST Regulations. The consideration payment date was scheduled for February 10, 2026, though no payments were required due to zero acceptance.